These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21738504)

  • 1. A case of advanced hepatocellular carcinoma with portal vein tumor thrombus refractory to epirubicin that showed marked decrease in tumor markers after transcatheter arterial infusion with miriplatin.
    Nishikawa H; Inuzuka T; Takeda H; Nakajima J; Sakamoto A; Henmi S; Ishikawa T; Saito S; Kita R; Kimura T; Osaki Y; Koshikawa Y
    Case Rep Oncol; 2011 May; 4(2):327-35. PubMed ID: 21738504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival with double platinum therapy transcatheter arterial infusion using cisplatin and transcatheter arterial chemoembolization using miriplatin for BCLC-B hepatocellular carcinoma.
    Ishikawa T; Abe S; Watanabe T; Nozawa Y; Sano T; Iwanaga A; Seki K; Honma T; Yoshida T
    Mol Clin Oncol; 2016 Nov; 5(5):511-516. PubMed ID: 27882236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial.
    Otsuji K; Takai K; Nishigaki Y; Shimizu S; Hayashi H; Imai K; Suzuki Y; Hanai T; Ideta T; Miyazaki T; Tomita E; Shimizu M; Moriwaki H
    Hepatol Res; 2015 May; 45(5):514-22. PubMed ID: 24961745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete pathological response to transcatheter arterial infusion despite a rapidly progressing recurrent hepatocellular carcinoma with portal vein tumor thrombus: A case report.
    Taguchi M; Sakuma Y; Sasanuma H; Sata N; Lefor AK; Sasaki T; Tanaka A; Yasuda Y
    Int J Surg Case Rep; 2015; 10():20-4. PubMed ID: 25790913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization with miriplatin-lipiodol emulsion for neuroendocrine metastases of the liver.
    Iwazawa J; Ohue S; Yasumasa K; Mitani T
    World J Radiol; 2010 Dec; 2(12):468-71. PubMed ID: 21225002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma.
    Tawada A; Chiba T; Ooka Y; Kanogawa N; Saito T; Motoyama T; Ogasawara S; Suzuki E; Kanai F; Yoshikawa M; Yokosuka O
    Anticancer Res; 2015 Jan; 35(1):549-54. PubMed ID: 25550601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of advanced hepatocellular carcinoma with portal vein tumor thrombus responding to transcatheter arterial infusion chemotherapy using cisplatin].
    Usui T; Shiozawa S; Kim DH; Tsuchiya A; Masuda T; Inose S; Aizawa M; Yoshimatsu K; Katsube T; Naritaka Y; Ogawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2359-61. PubMed ID: 20037422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison of the therapeutic efficacies between miriplatin and epirubicin.
    Handa T; Imai Y; Sugawara K; Chikayama T; Nakazawa M; Ando S; Hamaoka K; Inao M; Nakayama N; Mochida S
    Hepatol Res; 2014 Oct; 44(11):1072-80. PubMed ID: 23957866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
    Shirono T; Iwamoto H; Niizeki T; Shimose S; Nakano M; Satani M; Okamura S; Noda Y; Kamachi N; Kuromatsu R; Sakai M; Nomiyama M; Kuwano T; Tanaka M; Koga H; Torimura T
    Oncology; 2019; 96(2):79-86. PubMed ID: 30293080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomized, controlled study of the efficacy of transcatheter arterial chemoembolization with miriplatin for hepatocellular carcinoma.
    Kubota K; Hidaka H; Nakazawa T; Okuwaki Y; Yamane K; Inoue T; Uojima H; Takada J; Tanaka Y; Shibuya A; Fujii K; Woodhams R; Matsunaga K; Kokubu S; Koizumi W
    Hepatol Res; 2018 Feb; 48(3):E98-E106. PubMed ID: 28656607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective study.
    Goda Y; Morimoto M; Irie K; Kobayashi S; Ueno M; Moriya S; Tezuka S; Ohkawa S; Morinaga S; Numata K; Tanaka K; Maeda S
    Jpn J Clin Oncol; 2017 Dec; 47(12):1151-1156. PubMed ID: 28977459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcatheter arterial chemotherapy using a novel lipophilic platinum derivative (miriplatin) for patients with small and multiple hepatocellular carcinomas.
    Yukisawa S; Ishii H; Kasuga A; Matsuyama M; Kuraoka K; Takano K; Ozaka M
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):583-8. PubMed ID: 22330234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin.
    Iwazawa J; Ohue S; Hashimoto N; Mitani T
    Cancer Manag Res; 2012; 4():113-9. PubMed ID: 22570565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor efficacy of transcatheter arterial chemoembolization with warmed miriplatin in hepatocellular carcinoma.
    Seko Y; Ikeda K; Kawamura Y; Fukushima T; Hara T; Sezaki H; Hosaka T; Akuta N; Suzuki F; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Hepatol Res; 2013 Sep; 43(9):942-9. PubMed ID: 23301851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination Therapy by Transarterial Injection of Miriplatin-Iodized Oil Suspension with Microwave Ablation for Medium-Sized Hepatocellular Carcinoma: the Preliminary Experience.
    Kanaya M; Miyamoto N; Fujii T; Kudo K; Kinota N; Kato H
    Interv Radiol (Higashimatsuyama); 2022 Mar; 7(1):1-8. PubMed ID: 35911877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter arterial chemotherapy with miriplatin for hepatocellular carcinoma patients with chronic renal failure: report of three cases.
    Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Gut Liver; 2013 Mar; 7(2):246-51. PubMed ID: 23560163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk.
    Kosaka Y; Kawaoka T; Aikata H; Suehiro Y; Yamaoka K; Ando Y; Namba M; Takeuchi Y; Fujii Y; Uchikawa S; Kodama K; Oya K; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Baba Y; Awai K; Kimura T; Nagata Y; Chayama K
    Clin J Gastroenterol; 2020 Oct; 13(5):839-843. PubMed ID: 31974811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transarterial chemoembolization with miriplatin plus epirubicin on local control of hepatocellular carcinoma: a retrospective comparison with miriplatin monotherapy.
    Hashimoto N; Iwazawa J; Ohue S; Mitani T
    Onco Targets Ther; 2013; 6():1025-30. PubMed ID: 23986641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial safety and outcomes of miriplatin plus low-dose epirubicin for transarterial chemoembolisation of hepatocellular carcinoma.
    Iwazawa J; Hashimoto N; Ohue S; Mitani T
    Anticancer Res; 2012 Nov; 32(11):5039-44. PubMed ID: 23155276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.